Total Payments
$3,304
2024 Payments
$1,162
Companies
32
Transactions
218
Medicare Patients
4,366
Medicare Billing
$701,999
Payment Breakdown by Category
Food & Beverage$3,304 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,304 | 218 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,171 | 98 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $797.92 | 44 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $153.60 | 8 | $0 (2024) |
| Gilead Sciences, Inc. | $107.60 | 1 | $0 (2022) |
| GENZYME CORPORATION | $104.99 | 5 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $92.73 | 6 | $0 (2024) |
| Genentech USA, Inc. | $88.99 | 6 | $0 (2024) |
| Mylan Specialty L.P. | $81.73 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $77.59 | 5 | $0 (2024) |
| Amgen Inc. | $63.92 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,162 | 73 | AstraZeneca Pharmaceuticals LP ($383.09) |
| 2023 | $863.78 | 54 | GlaxoSmithKline, LLC. ($301.16) |
| 2022 | $330.41 | 20 | GlaxoSmithKline, LLC. ($177.44) |
| 2021 | $108.11 | 8 | GlaxoSmithKline, LLC. ($108.11) |
| 2020 | $226.16 | 16 | GlaxoSmithKline, LLC. ($66.78) |
| 2019 | $311.90 | 26 | GlaxoSmithKline, LLC. ($161.37) |
| 2018 | $94.11 | 7 | AstraZeneca Pharmaceuticals LP ($37.19) |
| 2017 | $207.49 | 14 | GlaxoSmithKline, LLC. ($89.16) |
All Payment Transactions
218 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Immunology | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $1.30 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: NEUROLOGY | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $2.50 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Respiratory | ||||||
| 10/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ARALAST (Biological) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $6.53 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Obesity | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $9.37 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,097 | 1,545 | $478,843 | $168,154 |
| 2022 | 11 | 1,084 | 1,608 | $490,232 | $171,641 |
| 2021 | 13 | 1,114 | 1,696 | $528,619 | $188,273 |
| 2020 | 14 | 1,071 | 1,666 | $482,558 | $173,932 |
Total Patients
4,366
Total Services
6,515
Medicare Billing
$701,999
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 312 | 545 | $131,101 | $54,155 | 41.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 230 | 334 | $94,856 | $33,700 | 35.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 80 | 162 | $96,552 | $29,353 | 30.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 173 | 176 | $75,680 | $25,637 | 33.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 69 | 69 | $25,185 | $8,247 | 32.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 73 | 98 | $15,762 | $6,514 | 41.3% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 69 | 69 | $11,040 | $2,453 | 22.2% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 24 | 24 | $9,720 | $2,386 | 24.6% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 20 | 20 | $7,800 | $1,929 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 31 | $6,200 | $1,893 | 30.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 17 | $4,947 | $1,887 | 38.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 356 | 615 | $135,915 | $51,814 | 38.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 90 | 213 | $126,948 | $39,232 | 30.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 182 | 283 | $80,372 | $28,434 | 35.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 154 | 162 | $69,660 | $26,696 | 38.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 60 | 60 | $21,760 | $7,882 | 36.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 107 | 128 | $19,840 | $7,696 | 38.8% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 18 | 27 | $7,047 | $2,510 | 35.6% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 62 | 62 | $9,920 | $2,219 | 22.4% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 22 | 22 | $8,910 | $2,183 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 22 | $4,400 | $1,647 | 37.4% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 14 | 14 | $5,460 | $1,328 | 24.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 109 | 268 | $159,728 | $50,107 | 31.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 323 | 542 | $119,782 | $46,300 | 38.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 174 | 306 | $86,232 | $32,381 | 37.6% |
About Dr. Rohit Malik, M.D
Dr. Rohit Malik, M.D is a Pulmonary Disease healthcare provider based in Marlton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1396944039.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rohit Malik, M.D has received a total of $3,304 in payments from pharmaceutical and medical device companies, with $1,162 received in 2024. These payments were reported across 218 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,304).
As a Medicare-enrolled provider, Malik has provided services to 4,366 Medicare beneficiaries, totaling 6,515 services with total Medicare billing of $701,999. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Sleep Medicine, Critical Care Medicine
- Location Marlton, NJ
- Active Since 07/12/2007
- Last Updated 02/10/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1396944039
Products in Payments
- TRELEGY ELLIPTA (Drug) $600.37
- NUCALA (Biological) $268.64
- DUPIXENT (Biological) $244.84
- FASENRA (Biological) $243.75
- TEZSPIRE (Biological) $214.38
- BREZTRI (Drug) $108.55
- ANORO (Drug) $104.03
- ANORO ELLIPTA (Drug) $96.70
- FASENRA (Drug) $93.49
- WAKIX (Drug) $92.73
- AIRSUPRA (Drug) $84.39
- YUPELRI (Drug) $81.73
- BREO (Drug) $68.86
- OFEV (Drug) $51.29
- (8874) inCourage (Device) $49.42
- OPSUMIT (Drug) $47.18
- Xolair (Biological) $45.70
- BEVESPI AEROSPHERE (Drug) $43.92
- Activase (Biological) $43.29
- Sunosi (Drug) $35.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Marlton
Dr. Mark Weir, Mb Chb, MB CHB
Pulmonary Disease — Payments: $7,553
Pulmonary Disease $7,553
Dr. Eric Sztejman, Md, MD
Pulmonary Disease — Payments: $4,910
Pulmonary Disease $4,910
Dr. Emilio Mazza, Md, MD
Pulmonary Disease — Payments: $4,892
Pulmonary Disease $4,892
Allen Salm, Md, MD
Pulmonary Disease — Payments: $4,688
Pulmonary Disease $4,688
Abhishek Agarwal, Md, MD
Pulmonary Disease — Payments: $4,388
Pulmonary Disease $4,388
Matthew Gordon, Md, MD
Pulmonary Disease — Payments: $4,385
Pulmonary Disease $4,385